Institutional Ownership
Greenwich Lifesciences Inc
CUSIP 396879108COMGLSIQ1 2026
13D / 13G Filings
3
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
65.0%
Max % of class reported
Institutional Holders
60
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
3 filings · latest Jun 22, 2022
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 433.9K | $10.42M |
| 2 | Geode Capital Management, LLC | 155.5K | $3.74M |
| 3 | State Street Corp | 133.9K | $3.22M |
| 4 | Nuveen, LLC | 88.7K | $2.13M |
| 5 | Northern Trust Corp | 75.1K | $1.80M |
| 6 | Bank Of New York Mellon Corp | 46.5K | $1.12M |
| 7 | Russell Investments Group, Ltd. | 39.7K | $953.6K |
| 8 | Goldman Sachs Group Inc | 39.5K | $949.3K |
| 9 | Ancora Advisors LLC | 37.5K | $900.8K |
| 10 | Morgan Stanley | 29.8K | $716.4K |